All Relations between Neuromyelitis Optica and nmo

Publication Sentence Publish Date Extraction Date Species
Fei Wang, Yaou Liu, Jianjun Li, Matthew Sondag, Meng Law, Chi-Shing Zee, Huiqing Dong, Kuncheng L. Abnormal brain function in neuromyelitis optica: A fMRI investigation of mPASAT. European journal of radiology. vol 95. 2018-05-22. PMID:28987668. cognitive impairment with the neuromyelitis optica (nmo) patients is debated. 2018-05-22 2023-08-13 Not clear
Alice Bruscolini, Marta Sacchetti, Maurizio La Cava, Magda Gharbiya, Massimo Ralli, Alessandro Lambiase, Armando De Virgilio, Antonio Grec. Diagnosis and management of neuromyelitis optica spectrum disorders - An update. Autoimmunity reviews. vol 17. issue 3. 2018-05-21. PMID:29339316. neuromyelitis optica (nmo) and neuromyelitis optica spectrum disorders (nmosd) are a group of autoimmune conditions characterized by inflammatory involvement of the optic nerve, spinal cord and central nervous system. 2018-05-21 2023-08-13 Not clear
Shannon R Hinson, Ian C Clift, Ningling Luo, Thomas J Kryzer, Vanda A Lenno. Autoantibody-induced internalization of CNS AQP4 water channel and EAAT2 glutamate transporter requires astrocytic Fc receptor. Proceedings of the National Academy of Sciences of the United States of America. vol 114. issue 21. 2018-05-14. PMID:28461494. aquaporin-4 (aqp4) water channel-specific igg distinguishes neuromyelitis optica (nmo) from multiple sclerosis and causes characteristic immunopathology in which central nervous system (cns) demyelination is secondary. 2018-05-14 2023-08-13 Not clear
Sharon A Sagan, Andrés Cruz-Herranz, Collin M Spencer, Peggy P Ho, Lawrence Steinman, Ari J Green, Raymond A Sobel, Scott S Zamvi. Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4. Journal of visualized experiments : JoVE. issue 126. 2018-05-14. PMID:28872108. while it is recognized that aquaporin-4 (aqp4)-specific t cells and antibodies participate in the pathogenesis of neuromyelitis optica (nmo), a human central nervous system (cns) autoimmune demyelinating disease, creation of an aqp4-targeted model with both clinical and histologic manifestations of cns autoimmunity has proven challenging. 2018-05-14 2023-08-13 mouse
Tetsuya Akaishi, Ichiro Nakashim. Efficiency of antibody therapy in demyelinating diseases. International immunology. vol 29. issue 7. 2018-05-10. PMID:28910968. in multiple sclerosis (ms) and neuromyelitis optica (nmo) spectrum disorders, several monoclonal antibodies have been suggested to decrease the incidence of clinical relapse and the disease activity. 2018-05-10 2023-08-13 human
Jie Sun, Xianting Sun, Ningnannan Zhang, Qiuhui Wang, Huanhuan Cai, Yuan Qi, Ting Li, Wen Qin, Chunshui Y. Analysis of brain and spinal cord lesions to occult brain damage in seropositive and seronegative neuromyelitis optica. European journal of radiology. vol 94. 2018-05-09. PMID:28941756. according to aquaporin-4 antibody (aqp4-ab), neuromyelitis optica (nmo) can be divided into seropositive and seronegative subgroups. 2018-05-09 2023-08-13 Not clear
Youming Long, Junyan Liang, Rong Zhong, Linzhan Wu, Wei Qiu, Shaopeng Lin, Cong Gao, Xiaohui Chen, Xueping Zheng, Ning Yang, Min Gao, Zhanhang Wan. Aquaporin-4 antibody in neuromyelitis optica: re-testing study in a large population from China. The International journal of neuroscience. vol 127. issue 9. 2018-04-26. PMID:27838939. aquaporin-4 (aqp4) antibody sero-positivity is critically important in neuromyelitis optica (nmo). 2018-04-26 2023-08-13 Not clear
Xuehong Jin, Shaofang Pei, Yi Liu, Xia L. Clinical analysis of neuromyelitis optica presenting as intractable nausea, vomiting and hiccups. The International journal of neuroscience. vol 127. issue 10. 2018-04-23. PMID:27919188. intractable nausea, vomiting and hiccups (inh) are reported as possible initial manifestations of neuromyelitis optica (nmo), but not correctly identified. 2018-04-23 2023-08-13 Not clear
Hao Meng, Jun Xu, Chenling Pan, Jiaxing Cheng, Yue Hu, Yin Hong, Yuehai Shen, Hua Da. Cognitive dysfunction in adult patients with neuromyelitis optica: a systematic review and meta-analysis. Journal of neurology. vol 264. issue 8. 2018-04-18. PMID:27909800. the objective of this study was to investigate cognitive dysfunction in 24-60-year-old neuromyelitis optica (nmo) patients, demographically matched healthy subjects, and ms patients. 2018-04-18 2023-08-13 human
Sharon A Sagan, Ryan C Winger, Andrés Cruz-Herranz, Patricia A Nelson, Sarah Hagberg, Corey N Miller, Collin M Spencer, Peggy P Ho, Jeffrey L Bennett, Michael Levy, Marc H Levin, Alan S Verkman, Lawrence Steinman, Ari J Green, Mark S Anderson, Raymond A Sobel, Scott S Zamvi. Tolerance checkpoint bypass permits emergence of pathogenic T cells to neuromyelitis optica autoantigen aquaporin-4. Proceedings of the National Academy of Sciences of the United States of America. vol 113. issue 51. 2018-04-13. PMID:27940915. aquaporin-4 (aqp4)-specific t cells are expanded in neuromyelitis optica (nmo) patients and exhibit th17 polarization. 2018-04-13 2023-08-13 mouse
S Jarius, B Wildeman. Devic's disease before Devic: On the contribution of Friedrich Albin Schanz (1863-1923). Journal of the neurological sciences. vol 379. 2018-04-12. PMID:28716289. neuromyelitis optica (nmo, devic's disease) is an autoimmune disorder of the cns that mainly affects the optic nerves and spinal cord and, if not treated, can leave patients blind and wheelchair-bound. 2018-04-12 2023-08-13 Not clear
Ignacio Fuentes Fernandez, Rocio Hernandez-Clares, Ester Carreón Guarnizo, Jose E Meca Lallan. Capillary leak syndrome in neuromyelitis optica treated with rituximab. Multiple sclerosis and related disorders. vol 16. 2018-04-12. PMID:28755680. 61-year-old woman with neuromyelitis optica (nmo) diagnosis treated with rituximab was referred to our hospital with severe hypovolemic shock and anasarca. 2018-04-12 2023-08-13 Not clear
Tetsuya Akaishi, Ichiro Nakashima, Douglas Kazutoshi Sato, Toshiyuki Takahashi, Kazuo Fujihar. Neuromyelitis Optica Spectrum Disorders. Neuroimaging clinics of North America. vol 27. issue 2. 2018-04-10. PMID:28391784. neuromyelitis optica (nmo) is clinically characterized by severe optic neuritis and transverse myelitis, but recent studies with anti-aquaporin-4-antibody specific to nmo have revealed that the clinical spectrum is wider than previously thought. 2018-04-10 2023-08-13 Not clear
Tomohiko Uchida, Masahiro Mori, Akiyuki Uzawa, Hiroki Masuda, Mayumi Muto, Ryohei Ohtani, Satoshi Kuwabar. Increased cerebrospinal fluid metalloproteinase-2 and interleukin-6 are associated with albumin quotient in neuromyelitis optica: Their possible role on blood-brain barrier disruption. Multiple sclerosis (Houndmills, Basingstoke, England). vol 23. issue 8. 2018-04-05. PMID:27682231. inflammation in neuromyelitis optica (nmo) is triggered by a serum antibody against the aquaporin-4 (aqp4). 2018-04-05 2023-08-13 Not clear
Sonia Patricia Castedo Paz, Luciana Branco, Marina Alves de Camargo Pereira, Caroline Spessotto, Yara Dadalti Fragos. Systematic review of the published data on the worldwide prevalence of John Cunningham virus in patients with multiple sclerosis and neuromyelitis optica. Epidemiology and health. vol 40. 2018-04-03. PMID:29370683. jcv can cause progressive multifocal leukoencephalopathy (pml) in immunosuppressed individuals, including those undergoing treatment for multiple sclerosis (ms) and neuromyelitis optica (nmo). 2018-04-03 2023-08-13 human
Fumitaka Shimizu, Kristin L Schaller, Gregory P Owens, Anne C Cotleur, Debra Kellner, Yukio Takeshita, Birgit Obermeier, Thomas J Kryzer, Yasuteru Sano, Takashi Kanda, Vanda A Lennon, Richard M Ransohoff, Jeffrey L Bennet. Glucose-regulated protein 78 autoantibody associates with blood-brain barrier disruption in neuromyelitis optica. Science translational medicine. vol 9. issue 397. 2018-03-30. PMID:28679661. neuromyelitis optica (nmo) is an inflammatory disorder mediated by antibodies to aquaporin-4 (aqp4) with prominent blood-brain barrier (bbb) breakdown in the acute phase of the disease. 2018-03-30 2023-08-13 mouse
Abigail M Methley, Kerry Mutch, Perry Moore, Anu Jaco. Development of a patient-centred conceptual framework of health-related quality of life in neuromyelitis optica: a qualitative study. Health expectations : an international journal of public participation in health care and health policy. vol 20. issue 1. 2018-03-19. PMID:26599425. neuromyelitis optica (nmo) is an auto-immune disease that can cause severe visual and mobility impairments. 2018-03-19 2023-08-13 Not clear
V Rakocevic-Stojanovic, S Peric, I Dujmovic, J Drulovic, J Pesovic, D Savic-Pavicevi. Neuromyelitis Optica in a Patient from Family with both Myotonic Dystrophy Type 1 and 2. Journal of neuromuscular diseases. vol 4. issue 1. 2018-03-15. PMID:28106565. the aim of this study was to present a family co-segregating myotonic dystrophy type 1 (dm1) and 2 (dm2), and one member affected with neuromyelitis optica (nmo). 2018-03-15 2023-08-13 Not clear
Jing Xu, Fang Zhang, Chao Gao, Xiaofeng Ma, Xiaolin Peng, Dexin Kong, Junwei Ha. Microarray Analysis of lncRNA and mRNA Expression Profiles in Patients with Neuromyelitis Optica. Molecular neurobiology. vol 54. issue 3. 2018-03-14. PMID:26941100. for the epigenetic characterization of neuromyelitis optica (nmo), we determined whether messenger rnas (mrnas) and long noncoding rnas (lncrnas) are expressed differentially in subjects with and without nmo. 2018-03-14 2023-08-13 human
Shahd Hm Hamid, Liene Elsone, Kerry Mutch, Tom Solomon, Anu Jaco. The impact of 2015 neuromyelitis optica spectrum disorders criteria on diagnostic rates. Multiple sclerosis (Houndmills, Basingstoke, England). vol 23. issue 2. 2018-03-13. PMID:27553618. the international panel for neuromyelitis optica (nmo) diagnosis has proposed diagnostic criteria for neuromyelitis optica spectrum disorders (nmosd). 2018-03-13 2023-08-13 Not clear